Skip Ribbon Commands
Skip to main content
PT EN

HASLab takes part in international project to improve safety of medical devices Back

Monday, 1/29/2018   
HASLab
International project aims at improving safety of medical devices such as glucose monitors and hemodialysis equipment, in order to reduce errors in use.
Currently, more than ever, health professional staff and patients trust the interaction between medical devices, such as injection pumps, cardiac monitors or diabetes devices. “Therefore, it is important that these devices communicate to each other and run trustworthily”, the researchers referred, speaking to the Portuguese news agency Lusa.

José Creissac, professor from the Department of Informatics of the School of Engineering of the University of Minho (EEUM) and researcher at the High Assurance Software Laboratory of the EEUM (HASLab/INESC TEC), is one of the two Portuguese researchers in the team. “The main goal of the ‘Medical Devices Interoperability’ project is to transform how medical devices are designed, tested, bought and used, thus reducing the number of medical errors and, consequently, saving lives”, he affirms.

The research is based on a study carried out by the Food and Drug Administration (FDA), the North American agency responsible for controlling food, drugs and medical devices, in collaboration with INESC TEC. Using data from 2012 to 2015, the research concluded that 12% of recall orders of medical devices were due to software problems, many of which detected through nurse-machine interaction. In 2% of the cases, those devices could have led the health professional to make a decision which could potentially endanger the patient’s life, the researchers added.

One of the project’s goals is to ensure that device designers and manufacturers produce and supply information on their performance, functioning and characteristics, so that users may operate them safely.

The project will also result in a norm which, after approval, will serve as a guideline for regulations to be created in the United States and, most likely, in Europe, Portugal included.

Source: Lusa

+ info: https://www.fda.gov/medicaldevices/scienceandresearch/researchprograms/ucm477390.htm
HASLab